申请人:Kobenhavns Universitet
公开号:US20140235576A1
公开(公告)日:2014-08-21
The present invention relates to compounds of Formula (I), combinations and use thereof for disease therapy, or pharmaceutically acceptable salt or solvate thereof, including all tautomers, stereoismers and polymorphs thereof, which are iGluR receptor inhibitors, and hence are useful in the treatment of psychiatric diseases or neurological disorders or a disease or disorder associated with abnormal activities of iGluR receptors.
本发明涉及式(I)的化合物,其组合物及其在疾病治疗中的应用,或其药学上可接受的盐或溶剂,包括其所有互变异构体、立体异构体和多晶形,它们是iGluR受体抑制剂,因此在治疗精神疾病或神经系统疾病或与iGluR受体异常活动相关的疾病或疾病中有用。